As non-invasive and economical steps in the diagnosis of a mitochondrial disease, the peptide molecule fibroblast-growth-factor-21 (FGF-21) and growth-differentiation-factor-15 (GDF-15) are established biomarkers. This evidence concerns the gene FGF21 and inborn mitochondrial metabolism disorder.